RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 AIM-HIGH: Niacin Provides No Added Benefit for Statin Users with Well-Controlled LDL
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 15
SP 16
OP 17
DO 10.1177/155989771115010
UL http://mdc.sagepub.com/content/11/15/16.abstract
AB Add-on therapy with high-dose extended-release niacin provides no additional reduction in cardiovascular events in patients with dyslipidemia and a history of cardiovascular disease who are treated to target low-density lipoprotein levels with a statin, according to findings from a randomized trial.